Shared Decision-making and Antimicrobial Stewardship in Secondary Care

NCT06605820 | Recruiting

• 1 other identifier: 2023.RCHT.05
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 2

Brief Summary

To identify opportunities for antibiotic prescribing shared decision making between patients and prescribers in secondary care.

Conditions

Antibiotic Prescribing is the Study Focus (no Condition)

Outcome Measures

Primary Outcomes (1)

• Patient and prescriber views and experiences with shared decision making (SDM) around antibiotic prescribing in secondary care and to identify further opportunities for SDM.

  Data will be analysed using thematic analysis

  1 year

Study Arms (2)

Patients

Other: None - Interview Only

Healthcare workers

Other: None - Interview Only

Interventions

None - Interview Only OTHER

None - Interview Only

Healthcare workers; Patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

We will use semi-structured interviews with patients and clinicians to address the research question. Patients that have received antibiotics during a recent inpatient stay will be identified using the hospital electronic prescribing system and a letter inviting study participation will be included in their discharge medication pack. Senior prescribing decision makers will be recruited from participating hospitals.

You may qualify if:

• For clinicians:
• Participant is willing and able to give informed consent for participation in the study.
• Senior registrar or consultant medical or surgical doctor working at participating hospitals and caring for inpatients.
• Fluent in English.
• For patients:
• Participant is willing and able to give informed consent for participation in the study.
• Male or Female, aged 16 years or above (no upper age limit).
• Good standard of speaking English and able to read and understand study materials.
• Received antibiotic for treatment of suspected or confirmed bacterial infection during inpatient stay.

You may not qualify if:

• For clinicians:
• Prescribers not currently caring for inpatients
• For patients:
• Patient who received prophylaxis antibiotics only

Sponsors & Collaborators

• Royal Cornwall Hospitals Trust: lead
• University of Oxford: collaborator

Study Sites (2)

Royal Cornwall Hospital

Truro, Cornwall, TR1 3LJ, United Kingdom

RECRUITING

Chelsea and Westminster Hospital

Truro, TR1 3LJ, United Kingdom

RECRUITING

Central Study Contacts

Verity Teague

CONTACT

44 01872256429; rcht.sponsor@nhs.net

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 18, 2024
• First Posted: September 20, 2024
• Study Start: September 3, 2024
• Primary Completion: July 1, 2025
• Study Completion: July 1, 2025
• Last Updated: June 4, 2025

Record last verified: 2025-05

Locations

GB (2)